SEOUL, Feb. 8 (Korea Bizwire) – AstraZeneca will start delivering the first batch of its COVID-19 vaccine to South Korea starting from Feb. 24, South Korean health authorities said Monday. The virus response control tower said in a statement that AstraZeneca’s vaccine will be supplied in phases from Feb. 24 over the following several days, [...]
SEOUL, Feb. 1 (Korea Bizwire) — A South Korean panel of experts has said that vaccines for the novel coronavirus by AstraZeneca can be administered to elderly people amid efficacy controversies, according to the country’s drug safety agency Monday. The independent advisory board announced its review on efficacy and safety of the vaccines developed by [...]
SEOUL, Dec. 3 (Korea Bizwire) — South Korea has signed a deal with British-Swedish bio giant AstraZeneca Plc. to purchase the company’s COVID-19 vaccine, health officials said Thursday. Seoul, however, didn’t disclose the details of the contract, including financial terms and the amount of vaccines to be bought. “(South Korea) recently signed a vaccine supply [...]
SEOUL, Sept. 22 (Korea Bizwire) — South Korea’s top pharmaceutical firm, Samsung Biologics Co., said Tuesday it has signed a long-term supply agreement, valued at approximately US$330.8 million, with British-Swedish bio giant AstraZeneca Plc. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its third plant [...]
SEOUL, July 21 (Korea Bizwire) — South Korea’s SK Bioscience inked a deal with global pharmaceutical company AstraZeneca to supply a candidate material for a coronavirus vaccine, the local biotech company said Tuesday. The letter of intent (LOI) reached between the two companies and the Ministry of Health and Welfare calls for close cooperation on [...]
LONDON, Jul. 8 (Korea Bizwire) — Today, the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the Alliance will [...]
CAMBRIDGE, United Kingdom, Apr. 16 (Korea Bizwire) — AstraZeneca and MedImmune, its global biologics research and development arm, today presented efficacy and safety data from two Phase I trials evaluating Imfinzi (durvalumab) in combination with tremelimumab in 2nd-line immunotherapy-naïve patients with either non-squamous advanced non-small cell lung cancer (NSCLC) (Study 006) or metastatic urothelial carcinoma [...]